Prevent & Sustain KY — Weight Loss Therapy
Clinically proven GLP-1 weight loss therapy — personalized, supervised, and delivered to your door.
The Process
Our medical team guides you through every step — from initial consultation to ongoing dose adjustments and lifestyle coaching.
Meet with our clinical team to review your health history, goals, and determine which therapy is right for you.
Our licensed providers issue your personalized prescription with a custom dose titration schedule.
Your medication ships directly to your door, discreetly packaged with administration instructions.
Monthly check-ins, dose optimization, and continuous access to your care team as your body transforms.
Medication Options
Two powerful, FDA-approved therapies. Both deliver real results — your provider will help determine which is the best fit.
GLP-1 Receptor Agonist — Once-Weekly Injectable
A once-weekly injectable that works by mimicking a natural gut hormone to reduce appetite, slow digestion, and help your body regulate blood sugar — leading to consistent, sustainable weight loss.
Starting from
per month
* Price shown is for starting dosage. Pricing varies by dosage.
Key Benefits
Significant weight reduction — Clinical trials show an average of 10–15% total body weight loss over 68 weeks.
Appetite suppression — Signals the brain's satiety center, reducing hunger and cravings between meals.
Blood sugar regulation — Improves insulin sensitivity and lowers fasting glucose levels.
Cardiovascular protection — Shown to reduce risk of major cardiovascular events in at-risk adults.
Once-weekly dosing — Simple self-injection, same day each week, for a low-burden routine.
Improved metabolic markers — Reduces triglycerides, LDL cholesterol, and blood pressure over time.
Dual GIP + GLP-1 Agonist — Once-Weekly Injectable
A next-generation dual-action injectable that activates two hormonal pathways simultaneously — delivering superior weight loss results compared to single-receptor therapies. Ideal for those seeking maximum impact.
Starting from
per month
* Price shown is for starting dosage. Pricing varies by dosage.
Key Benefits
Superior weight loss — Studies show up to 20–22% total body weight loss, outperforming all other GLP-1 therapies.
Dual hormone activation — Acts on both GIP and GLP-1 receptors for a synergistic metabolic effect unmatched by single-pathway drugs.
Powerful appetite control — Stronger and more sustained appetite reduction, including reduced food noise and emotional eating.
Exceptional glucose control — Outperforms semaglutide in A1C reduction, with proven benefits for Type 2 diabetes management.
Lean mass preservation — Emerging research suggests better preservation of muscle mass during fat loss compared to other GLP-1s.
Rapid, visible results — Many patients report noticeable changes within the first 4–8 weeks of therapy.
Side by Side
Head-to-head clinical trial data comparing Tirzepatide and Semaglutide over 72 weeks in adults with obesity.
Over 72 weeks, both medications delivered meaningful weight reduction. Tirzepatide demonstrated 47% greater average weight loss compared to Semaglutide.
A key measure of transformative results. Tirzepatide tripled the rate of participants reaching this exceptional weight loss milestone compared to Semaglutide.
Both treatments produced meaningful reductions in waist circumference — a critical indicator of visceral fat loss and overall metabolic health improvement.
Across every milestone, a greater percentage of Tirzepatide participants achieved clinically significant weight loss thresholds compared to Semaglutide.
Data sourced from a 72-week head-to-head clinical trial published in the New England Journal of Medicine comparing Tirzepatide and Semaglutide in adults with obesity without diabetes.
Questions
Begin Today
Schedule your free consultation and our Kentucky-licensed clinical team will guide you to the right path — confidentially and compassionately.
Schedule Free Consultation